Reed, Domonique M.
Radin, Elizabeth
Kim, Evelyn
Wadonda-Kabondo, Nellie
Payne, Danielle
Gillot, Myrline
Jahn, Andreas
Bello, George
Kalua, Thokozani
Justman, Jessica E.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32AI114398)
Centers for Disease Control and Prevention (U2GPS002005)
Article History
Received: 17 April 2023
Accepted: 23 January 2024
First Online: 22 February 2024
Declarations
:
: The household head consented to the household questionnaire on behalf of the household; heads of households were adults aged 18–64 years or emancipated individuals with no parent or guardian or not living with their parent/guardian. Informed consent was documented electronically on the tablet with a signature or other mark by the interviewer on the consent form’s designated field. To participate in the study, adolescents aged 15–17 years provided written assent, and their parents or guardians provided written informed consent. Written informed consent or assent was documented via electronic signature, with witnesses verifying consent for illiterate individuals. The Centers for Disease Control and Prevention Institutional Review Board (IRB), the Columbia University Irving Medical Center IRB, and National Health Science Research Committee of Malawi approved the protocol for MPHIA. All methods were carried out in accordance with relevant guidelines and regulations outlined by the Declaration of Helsinki.
: Not applicable.
: The authors have no conflicts of interest to disclose.